Mycofeast

Mycofeast is a biotechnology company founded in 2023, dedicated to advancing the dairy industry through precision fermentation techniques. The company has established itself as a leader in the development of innovative dairy products, leveraging cutting-edge technology and scientific discovery.

Locations and Facilities

Mycofeast operates facilities in Britain, the United States, and Poland. These strategic locations enable the company to leverage diverse markets and expertise in the dairy industry, enhancing its manufacturing and distribution capabilities.

Innovation and Technology

The company's innovation is driven by Evolutia Bio, a platform that integrates artificial intelligence discovery, high-throughput screening, and genetic engineering. This platform is central to Mycofeast's approach to developing new strains and processes that are integral to its precision-fermented dairy products.

Key Events

A significant milestone for Mycofeast was the acquisition of Daisy Lab, a move aimed at expanding its precision-fermented dairy capabilities. This acquisition reflects the company's commitment to growth and innovation in the dairy sector.

Focus and Development

Mycofeast is committed to scientific discovery and the development of strains and processes that enable industrial manufacturing. The company also emphasizes market access, ensuring that its innovative products reach a broad consumer base.